vs

Side-by-side financial comparison of Brilliant Earth Group, Inc. (BRLT) and Zai Lab Ltd (ZLAB). Click either name above to swap in a different company.

Zai Lab Ltd is the larger business by last-quarter revenue ($127.1M vs $124.4M, roughly 1.0× Brilliant Earth Group, Inc.). On growth, Zai Lab Ltd posted the faster year-over-year revenue change (17.1% vs 4.1%). Brilliant Earth Group, Inc. produced more free cash flow last quarter ($5.7M vs $-26.7M). Over the past eight quarters, Zai Lab Ltd's revenue compounded faster (20.8% CAGR vs 13.1%).

Brilliant Earth is an American company that sells jewelry featuring diamonds and other gemstones that are asserted to be ethically sourced. The company was established in August 2005 by Beth Gerstein and Eric Grossberg, and is headquartered in San Francisco, California. According to Businessweek, the company has been influential in creating a market for ethically sourced jewelry. Some provenance claims were disputed as per a 2017 The Next Web article.

Zai Lab Ltd is a global biopharmaceutical company focused on developing, manufacturing and commercializing innovative therapies for oncology, autoimmune disorders, infectious diseases and other unmet medical needs. It operates primarily in the Greater China region and partners with leading global biotech firms to expand access to life-saving treatments for underserved patient populations.

BRLT vs ZLAB — Head-to-Head

Bigger by revenue
ZLAB
ZLAB
1.0× larger
ZLAB
$127.1M
$124.4M
BRLT
Growing faster (revenue YoY)
ZLAB
ZLAB
+13.0% gap
ZLAB
17.1%
4.1%
BRLT
More free cash flow
BRLT
BRLT
$32.4M more FCF
BRLT
$5.7M
$-26.7M
ZLAB
Faster 2-yr revenue CAGR
ZLAB
ZLAB
Annualised
ZLAB
20.8%
13.1%
BRLT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BRLT
BRLT
ZLAB
ZLAB
Revenue
$124.4M
$127.1M
Net Profit
$-2.9M
Gross Margin
55.9%
51.0%
Operating Margin
-0.0%
-54.6%
Net Margin
-2.3%
Revenue YoY
4.1%
17.1%
Net Profit YoY
-908.9%
EPS (diluted)
$-0.20
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BRLT
BRLT
ZLAB
ZLAB
Q4 25
$124.4M
$127.1M
Q3 25
$110.3M
$115.4M
Q2 25
$108.9M
$109.1M
Q1 25
$93.9M
$105.7M
Q4 24
$119.5M
$108.5M
Q3 24
$99.9M
$101.8M
Q2 24
$105.4M
$100.1M
Q1 24
$97.3M
$87.1M
Net Profit
BRLT
BRLT
ZLAB
ZLAB
Q4 25
$-2.9M
Q3 25
$-107.0K
$-36.0M
Q2 25
$-166.0K
$-40.7M
Q1 25
$-466.0K
$-48.4M
Q4 24
$358.0K
Q3 24
$-141.0K
$-41.7M
Q2 24
$185.0K
$-80.3M
Q1 24
$139.0K
$-53.5M
Gross Margin
BRLT
BRLT
ZLAB
ZLAB
Q4 25
55.9%
51.0%
Q3 25
57.6%
59.5%
Q2 25
58.3%
60.6%
Q1 25
58.6%
63.6%
Q4 24
59.6%
61.5%
Q3 24
60.8%
64.1%
Q2 24
60.8%
64.9%
Q1 24
59.9%
61.4%
Operating Margin
BRLT
BRLT
ZLAB
ZLAB
Q4 25
-0.0%
-54.6%
Q3 25
-0.6%
-42.3%
Q2 25
-1.1%
-50.3%
Q1 25
-3.8%
-53.3%
Q4 24
2.0%
-62.6%
Q3 24
-1.1%
-66.6%
Q2 24
1.1%
-76.0%
Q1 24
0.9%
-80.7%
Net Margin
BRLT
BRLT
ZLAB
ZLAB
Q4 25
-2.3%
Q3 25
-0.1%
-31.2%
Q2 25
-0.2%
-37.3%
Q1 25
-0.5%
-45.8%
Q4 24
0.3%
Q3 24
-0.1%
-40.9%
Q2 24
0.2%
-80.2%
Q1 24
0.1%
-61.4%
EPS (diluted)
BRLT
BRLT
ZLAB
ZLAB
Q4 25
$-0.20
$-0.05
Q3 25
$-0.01
$-0.03
Q2 25
$-0.01
$-0.04
Q1 25
$-0.03
$-0.04
Q4 24
$0.02
$-0.09
Q3 24
$-0.01
$-0.04
Q2 24
$0.01
$-0.08
Q1 24
$0.01
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BRLT
BRLT
ZLAB
ZLAB
Cash + ST InvestmentsLiquidity on hand
$79.1M
$689.6M
Total DebtLower is stronger
$0
Stockholders' EquityBook value
$12.3M
$715.5M
Total Assets
$200.9M
$1.2B
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BRLT
BRLT
ZLAB
ZLAB
Q4 25
$79.1M
$689.6M
Q3 25
$73.4M
$717.2M
Q2 25
$133.6M
$732.2M
Q1 25
$147.3M
$757.3M
Q4 24
$161.9M
$779.7M
Q3 24
$152.7M
$616.1M
Q2 24
$152.2M
$630.0M
Q1 24
$147.5M
$650.8M
Total Debt
BRLT
BRLT
ZLAB
ZLAB
Q4 25
$0
Q3 25
$0
Q2 25
$34.5M
Q1 25
$54.5M
Q4 24
$55.7M
Q3 24
$58.1M
Q2 24
$58.0M
Q1 24
$58.8M
Stockholders' Equity
BRLT
BRLT
ZLAB
ZLAB
Q4 25
$12.3M
$715.5M
Q3 25
$12.0M
$759.9M
Q2 25
$15.3M
$791.7M
Q1 25
$14.9M
$810.8M
Q4 24
$15.3M
$840.9M
Q3 24
$14.5M
$667.7M
Q2 24
$14.1M
$704.2M
Q1 24
$13.3M
$762.2M
Total Assets
BRLT
BRLT
ZLAB
ZLAB
Q4 25
$200.9M
$1.2B
Q3 25
$203.0M
$1.2B
Q2 25
$260.9M
$1.2B
Q1 25
$269.6M
$1.2B
Q4 24
$281.2M
$1.2B
Q3 24
$273.2M
$985.3M
Q2 24
$272.5M
$987.4M
Q1 24
$268.2M
$988.4M
Debt / Equity
BRLT
BRLT
ZLAB
ZLAB
Q4 25
0.00×
Q3 25
0.00×
Q2 25
2.26×
Q1 25
3.65×
Q4 24
3.63×
Q3 24
4.01×
Q2 24
4.13×
Q1 24
4.43×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BRLT
BRLT
ZLAB
ZLAB
Operating Cash FlowLast quarter
$7.2M
$-26.0M
Free Cash FlowOCF − Capex
$5.7M
$-26.7M
FCF MarginFCF / Revenue
4.6%
-21.0%
Capex IntensityCapex / Revenue
1.2%
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$5.8M
$-158.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BRLT
BRLT
ZLAB
ZLAB
Q4 25
$7.2M
$-26.0M
Q3 25
$608.0K
$-32.0M
Q2 25
$9.1M
$-31.0M
Q1 25
$-7.1M
$-61.7M
Q4 24
$14.1M
$-55.8M
Q3 24
$2.0M
$-26.8M
Q2 24
$7.3M
$-42.2M
Q1 24
$-5.8M
$-90.1M
Free Cash Flow
BRLT
BRLT
ZLAB
ZLAB
Q4 25
$5.7M
$-26.7M
Q3 25
$-3.0K
$-35.0M
Q2 25
$7.9M
$-33.9M
Q1 25
$-7.9M
$-63.2M
Q4 24
$11.9M
$-58.4M
Q3 24
$674.0K
$-28.2M
Q2 24
$6.5M
$-42.9M
Q1 24
$-6.4M
$-91.1M
FCF Margin
BRLT
BRLT
ZLAB
ZLAB
Q4 25
4.6%
-21.0%
Q3 25
-0.0%
-30.4%
Q2 25
7.3%
-31.1%
Q1 25
-8.4%
-59.9%
Q4 24
10.0%
-53.8%
Q3 24
0.7%
-27.7%
Q2 24
6.1%
-42.9%
Q1 24
-6.5%
-104.5%
Capex Intensity
BRLT
BRLT
ZLAB
ZLAB
Q4 25
1.2%
0.5%
Q3 25
0.6%
2.6%
Q2 25
1.1%
2.6%
Q1 25
0.8%
1.5%
Q4 24
1.8%
2.4%
Q3 24
1.3%
1.3%
Q2 24
0.8%
0.7%
Q1 24
0.6%
1.1%
Cash Conversion
BRLT
BRLT
ZLAB
ZLAB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
39.36×
Q3 24
Q2 24
39.51×
Q1 24
-41.65×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BRLT
BRLT

US$120.3M97%
Non Us$4.2M3%

ZLAB
ZLAB

Zejula$56.0M44%
Other$21.9M17%
Nuzyra$16.0M13%
Optune$11.9M9%
XACDURO$10.7M8%
Qinlock$9.7M8%
AUGTYRO$836.0K1%

Related Comparisons